Skip to main content

Table 2 Description of studies in the meta-analysis and measures of test accuracy

From: Bacteriophage- based tests for the detection of Mycobacterium tuberculosis in clinical specimens: a systematic review and meta- analysis

Source

Country

Study Design

Blinding

Complete verification

Specimen

Treatment status

Test

Patients With TB (No./Overall)

Reference Standard

Sensitivity (95%CI)

Specificity (95%CI)

Commercial assays

Albay (2003)

Turkey

CS

Unclear

Yes

Sputum

Untreated

FASTPlaque

64/192

BACTEC

0.88 (0.77, .94)

0.97 (0.92, 0.99)

Albert (2002)

South Africa

CS

Unclear

Yes

Sputum

Untreated

FASTPlaque

207/1618

BACTEC

0.72 (0.66,0.78

0.99 (0.98,0.99)

Alcaide (2003)

Spain

CS

Unclear

Yes

Sputum+ other

Some treated

FASTPlaque

144/2048

B+LJ

0.58 (0.50,0.66)

0.99 (0.99,0.99)

Bellen (2003)

Philippines

CS

Unclear

Yes

Sputum

Some treated

Phage Tek

103/206

LJ

0.31 (0.22,0.41)

0.86 (0.78,0.92)

Butt (2004)

Pakistan

CS

Unclear

Yes

Sputum

Untreated

FASTPlaque

60/160

BACTEC

0.77 (0.64,0.87)

0.96 (0.90,0.99)

Cavusoglu (2002)

Turkey

CC

Unclear

Yes

Sputum

Some treated

FASTPlaque

33/63

LJ

0.30 (0.15,0.49)

0.97 (0.83,1.00)

Marei (2003)

Egypt

CS

Unclear

Yes

Sputum

Untreated

FASTPlaque

60/160

BACTEC

0.77 (0.64,0.87)

0.96 (0.90,0.99)

Mbulo (2004)

Zambia

CS

Yes

Yes

Sputum

Untreated

FASTPlaque

29/115

LJ

0.21 (0.08,0.40)

0.91 (0.82,0.96)

Muzaffar (2002)

Pakistan

CS

Unclear

Yes

Sputum

NR

FASTPlaque

103/1209

LJ

0.82 (0.76,0.86)

0.98 (0.95,0.99)

Shenai (2002)

India

CS

Unclear

Yes

Sputum+ other

Some treated

FASTPlaque

62/90

BACTEC+LJ

0.76 (0.60,0.89)

1.00 (0.74,1.00)

Shenai (2004)

India

CC

Unclear

Yes

Sputum+ other

Some treated

FASTPlaque

103/129

BACTEC+LJ

0.94 (0.79,0.99

0.83 (0.52,0.98)

In- house assays

McNerney (2004)

Zambia

CS

Yes

Yes

Sputum

NR

In-house

220/496

LJ

0.44 (0.37,0.51)

0.92 (0.89,0.95)

Mbulo (2004)

Zambia

CS

Yes

Yes

Sputum

Untreated

In – house

245/514

LJ+AMTD

0.45 (0.32,0.60)

0.95 (0.85,0.99)

  1. Abbreviations: CS, cross-sectional studies; CC, case-control studies; NR, Not recorded.